1. Home
  2. ATOS vs BAER Comparison

ATOS vs BAER Comparison

Compare ATOS & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • BAER
  • Stock Information
  • Founded
  • ATOS 2009
  • BAER 2014
  • Country
  • ATOS United States
  • BAER United States
  • Employees
  • ATOS N/A
  • BAER N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • BAER Blank Checks
  • Sector
  • ATOS Health Care
  • BAER Finance
  • Exchange
  • ATOS Nasdaq
  • BAER Nasdaq
  • Market Cap
  • ATOS 107.2M
  • BAER 112.7M
  • IPO Year
  • ATOS 2012
  • BAER N/A
  • Fundamental
  • Price
  • ATOS $0.84
  • BAER $1.89
  • Analyst Decision
  • ATOS Strong Buy
  • BAER Strong Buy
  • Analyst Count
  • ATOS 3
  • BAER 1
  • Target Price
  • ATOS $6.17
  • BAER $5.25
  • AVG Volume (30 Days)
  • ATOS 473.0K
  • BAER 144.4K
  • Earning Date
  • ATOS 11-11-2025
  • BAER 11-10-2025
  • Dividend Yield
  • ATOS N/A
  • BAER N/A
  • EPS Growth
  • ATOS N/A
  • BAER N/A
  • EPS
  • ATOS N/A
  • BAER N/A
  • Revenue
  • ATOS N/A
  • BAER $126,489,000.00
  • Revenue This Year
  • ATOS N/A
  • BAER $13.26
  • Revenue Next Year
  • ATOS N/A
  • BAER N/A
  • P/E Ratio
  • ATOS N/A
  • BAER N/A
  • Revenue Growth
  • ATOS N/A
  • BAER 72.69
  • 52 Week Low
  • ATOS $0.55
  • BAER $1.02
  • 52 Week High
  • ATOS $1.66
  • BAER $4.44
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 60.84
  • BAER 44.97
  • Support Level
  • ATOS $0.81
  • BAER $1.93
  • Resistance Level
  • ATOS $0.80
  • BAER $2.04
  • Average True Range (ATR)
  • ATOS 0.03
  • BAER 0.12
  • MACD
  • ATOS 0.01
  • BAER -0.02
  • Stochastic Oscillator
  • ATOS 92.67
  • BAER 18.59

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF (Super Scooper) aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: